The Department of Justice announced today a resolution of a foreign bribery investigation into Balt SAS (Balt), a medical device company headquartered in France, relating to an alleged scheme to pay bribes to a physician who served in a senior role at a state-owned public hospital in France (the Official), in violation of the Foreign Corrupt Practices Act (FCPA).